
Doximity (DOCS) Stock Forecast & Price Target
Doximity (DOCS) Analyst Ratings
Bulls say
Doximity is a promising company with strong fundamentals and positive market reception. Its online platform for physicians and healthcare professionals provides multiple solutions, such as collaboration tools, career management, and virtual patient visits. The company's recent strong financial results and increased revenue guidance, driven by its AI search and Insights products, showcase its potential for growth in the healthcare market. With a strong leadership team in place and continued investments in AI and brand marketing, Doximity is well-positioned for success in the coming years.
Bears say
Doximity is a healthcare technology company providing an online platform for physicians and other healthcare professionals to collaborate and stay updated on the latest medical news and research. However, despite its strong user base, the company's core marketing solutions segment may face challenges from a declining number of pharmaceuticals under patent, potentially reducing revenue opportunities. Additionally, Doximity's recent investments in AI technologies may result in lower short-term profits and market share gains. The company's FY27 outlook for revenue and adjusted EBITDA is below consensus estimates, and its ability to grow above the industry market rate may be limited due to the delayed launch of its AI search commercial product.
This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.
Doximity (DOCS) Analyst Forecast & Price Prediction
Start investing in Doximity (DOCS)
Order type
Buy in
Order amount
Est. shares
0 shares